PMV Pharmaceuticals, Inc. (PMVP)

Last Closing Price: 1.22 (2026-11-18)

Earnings per Share (EPS) (Diluted) (Quarterly)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

PMV Pharmaceuticals, Inc. (PMVP) had Earnings per Share (EPS) (Diluted) of $-0.52 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-34.37M
--
--
$20.06M
$-20.06M
$-14.32M
$-34.38M
$-34.38M
$-34.37M
$-34.37M
$-34.37M
$-34.37M
$-20.06M
$-20.47M
66.23M
66.23M
$-0.52
Earnings per Share (EPS) (Diluted)
$-0.52
Balance Sheet Financials
$104.89M
$0.13M
$6.51M
$111.40M
$10.69M
--
$43.61M
$54.30M
$57.11M
$57.11M
$57.11M
75.53M
Cash Flow Statement Financials
$-52.44M
$-12.60M
$47.05M
$37.98M
$19.99M
$-17.99M
$4.54M
--
--
Fundamental Metrics & Ratios
9.81
--
--
--
--
--
--
--
--
--
--
$-52.44M
--
--
--
--
--
--
--
-60.19%
-60.19%
-30.85%
-60.19%
$0.76
$-0.79
$-0.79